EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy

Luca Pugliese iD, Alessandra Luciano iD, Marcello Chiocchi iD

Journal of Cardiovascular Development and Disease · 15.05.2025 · 12 (5) · 189

DOI: 10.3390/jcdd12050189 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 15.05.2025. Verfasst von Luca Pugliese und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Surgical Sciences and Translational Medicine, University of Rome La Sapienza, Radiology Unit, Sant'Andrea University Hospital, …. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy, caused by either sarcomere protein or other gene mutations. It is a complex and highly heterogeneous disorder, with phenotypes ranging from asymptomatic to severe disease, characterized by asymmetric left ventricular (LV) hypertrophy unexplained by loading conditions, which is also associated with myocardial fiber disarray, and preserved or increased ejection fraction without LV dilation. Comprehensive personal and family history, physical examination, and ECG testing raise suspicion of HCM, and echocardiogram represents the first-line imaging modality for confirming a diagnosis. Moreover, contrast-enhanced cardiac magnetic resonance (CMR) imaging has increasingly emerged as a fundamental diagnostic and prognostic tool in HCM management. This article reviews the role of CMR in HCM identification and differentiation from phenotypic mimics, characterization of HCM phenotypes, monitoring of disease progression, evaluation of pre- and post-septal reduction treatments, and selection of candidates for implantable cardioverter-defibrillator. By providing information on cardiac morphology and function and tissue characterization, CMR is particularly helpful in the quantification of myocardial wall thickness, the detection of hypertrophy in areas blind to echocardiogram, subtle morphologic features in the absence of LV hypertrophy, myocardial fibrosis, and apical aneurysm, the evaluation of LV outflow tract obstruction, and the assessment of LV function in end-stage dilated HCM.

Schlagwörter

Stichwörter der Autor:innen

cardiac magnetic resonance imaginghypertrophic cardiomyopathyleft ventricular hypertrophyleft ventricular outflow tract obstructionmyocardial fibrosis

Autor:innen und Institutionen

  • Department of Medical Surgical Sciences and Translational Medicine, University of Rome La Sapienza, Radiology Unit, Sant'Andrea University Hospital, 00189 Rome, Italy.
  • Department of Biomedicine and Prevention, University of Rome Tor Vergata, Unit of Diagnostic Imaging, Policlinico Tor Vergata, 00133 Rome, Italy.

ORCID-Profile: Luca Pugliese, Alessandra Luciano, Marcello Chiocchi

Zitieren

APA

Pugliese, L., Luciano, A., & Chiocchi, M. (2025). The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy. Journal of Cardiovascular Development and Disease, 12(5), 189. https://doi.org/10.3390/jcdd12050189

Vancouver

Pugliese L, Luciano A, Chiocchi M. The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy. Journal of Cardiovascular Development and Disease. 2025;12(5):189. doi:10.3390/jcdd12050189

BibTeX
@article{Pugliese2025,
  author = {Pugliese, Luca and Luciano, Alessandra and Chiocchi, Marcello},
  title = {The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2025},
  volume = {12},
  number = {5},
  pages = {189},
  doi = {10.3390/jcdd12050189}
}
Kostenlos starten →